248 related articles for article (PubMed ID: 32205033)
1. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.
Bianconi V; Banach M; Pirro M;
Trends Cardiovasc Med; 2021 May; 31(4):205-215. PubMed ID: 32205033
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
[TBL] [Abstract][Full Text] [Related]
4. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
Tada H; Takamura M; Kawashiri MA
Vasc Health Risk Manag; 2021; 17():59-67. PubMed ID: 33628029
[TBL] [Abstract][Full Text] [Related]
5. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
[TBL] [Abstract][Full Text] [Related]
6. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.
Oosterveer DM; Versmissen J; Yazdanpanah M; Hamza TH; Sijbrands EJ
Atherosclerosis; 2009 Dec; 207(2):311-7. PubMed ID: 19439299
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
[TBL] [Abstract][Full Text] [Related]
8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
9. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.
Wiegman A; Rodenburg J; de Jongh S; Defesche JC; Bakker HD; Kastelein JJ; Sijbrands EJ
Circulation; 2003 Mar; 107(11):1473-8. PubMed ID: 12654602
[TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
Pojskic L; Pojskic B
Atherosclerosis; 2018 Oct; 277():278-281. PubMed ID: 30270059
[TBL] [Abstract][Full Text] [Related]
11. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population.
Umans-Eckenhausen MA; Sijbrands EJ; Kastelein JJ; Defesche JC
Circulation; 2002 Dec; 106(24):3031-6. PubMed ID: 12473547
[TBL] [Abstract][Full Text] [Related]
14. The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.
Paquette M; Dufour R; Baass A
J Clin Lipidol; 2017; 11(1):80-86. PubMed ID: 28391914
[TBL] [Abstract][Full Text] [Related]
15. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
Trinder M; Cermakova L; Ruel I; Baass A; Paquette M; Wang J; Kennedy BA; Hegele RA; Genest J; Brunham LR
Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1683-1693. PubMed ID: 38779854
[TBL] [Abstract][Full Text] [Related]
16. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
Klaus G; Taylan C; Büscher R; Schmitt CP; Pape L; Oh J; Driemeyer J; Galiano M; König J; Schürfeld C; Spitthöver R; Schaefer JR; Weber LT; Heibges A; Klingel R
Pediatr Nephrol; 2018 Jul; 33(7):1199-1208. PubMed ID: 29502162
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
18. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
19. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
Miname MH; Santos RD
Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
